Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model (Q39011970)

8 September 2017

Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model (English)

1 reference

8 September 2017

1 reference

1 reference

Uterine serous carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

Rosemary Tambouret

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Jolijn W Groeneweg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Tracilyn R Hall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ling Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Minji Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sriram Sathayanrayanan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rosemary Foster

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Bo R Rueda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Whitfield B Growdon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

22 March 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

607-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Two pathogenetic types of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Uterine papillary serous cancer: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Notch signaling: cell fate control and signal integration in development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Notch signalling: a simple pathway becomes complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

The canonical Notch signaling pathway: unfolding the activation mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Notch signaling in pancreatic cancer: oncogene or tumor suppressor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Notch3 gene amplification in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Defining NOTCH3 target genes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Integrated genomic analyses of ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Diagnostic utility of notch-1 immunocytochemistry in endometrial cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

The pattern of expression of Notch protein members in normal and pathological endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Down-regulated expression of Notch signaling molecules in human endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Targeting notch signaling pathway in cancer: clinical development advances and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Rational targeting of Notch signaling in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Effects of N-[N-(3, 5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Targeting Notch to target cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.560

10.1016/J.YGYNO.2014.03.560

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24667249%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference